Our group previously described that PKCθ catalytic activity is essential for HIV-1 replication, as shown by PKCθ mRNA interference (20) or the use of selective PKCθ inhibitors (21), which reduced HIV-1 replication in CD4+ T cells and induced a refractory state to HIV-1 infection. The gene discussed is PRRT2; the disease is HIV-1 infection.